|
|
| SN |
Author |
Title |
Status |
| 3851 |
mudassar |
DIAGNOSTIC ACCURACY OF DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING IN DIAGNOSING MUSCLE INVASION IN URINARY BLADDER CANCER, TAKING HISTOPATHOLOGY AS GOLD STANDARD |
Accepted |
| 3852 |
Monday K. Sapira |
THE RISK OF SPREAD OF PRIMARY PROSTATE CANCER IN PATIENTS WITH THE DISEASE IN PORT HARCOURT, NIGER DELTA REGION OF SOUTHERN NIGERIA. |
Accepted |
| 3853 |
Mokhtar |
CHEMICAL INCOMPATIBILITIES OF I.V ADMIXTURE COMBINATIONS IN ICU, ORTHOPEDIC AND EMERGENCY UNITS OF VARIOUS HOSPITALS AND MEDICAL CENTERS IN SANA’A, YEMEN |
Accepted |
| 3854 |
Ayesha |
INFLAMMATORY BOWEL DISEASE-AN OBSERVATIONAL STUDY ON RISK FACTORS AND MEDICATION MANAGEMENT |
Accepted |
| 3855 |
Narendra varma J |
A CROSS-SECTIONAL STUDY ON DRUG UTILIZATION AND IT’S COST ANALYSIS IN THE UROLOGY DEPARTMENT OF A TERTIARY CARE HOSPITAL |
Under Review |
| 3856 |
Md.Yousuf |
CLINICO-RADIOLOGICAL OUTCOME OF
PERCUTANEOUS VERTEBROPLASTY IN DORSO-LUMBAR
OSTEOPOROTIC VERTEBRAL COMPRESSION FRACTURES (OVCFS)
|
Accepted |
| 3857 |
Suresha D.N. |
NOVEL UV-SPECTROPHOTOMETRIC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF AMLODIPINE IN BULK AND PHARMACEUTICAL FORMULATION |
Accepted |
| 3858 |
Deepak |
"RASAYANA CHIKITSA: THE ANCIENT ART OF REJUVENATION AND OVERALL WELLNESS" |
Under Review |
| 3859 |
Mohamad Y. Rezk |
ROLE OF ASPROSIN IN OBESITY, DIABETES, AND METABOLIC SYNDROME |
Accepted |
| 3860 |
Anjali |
SIMILARITY BASED DESIGN, SYNTHESIS AND CHARACTERIZATION OF ISONIAZID ANALOGUES AND THEIR THERAPEUTIC POTENTIAL |
Under Review |
| 3861 |
Sonam Rawat |
ROLE OF PATHYA – APATHYAG IN VATARAKTA
W.S.R TO GOUT
|
Accepted |
| 3862 |
Ambikaprasad |
DANTOTPATTI: A CONCEPTUAL STUDY |
Accepted |
| 3863 |
Pursora Alok Singh |
AYURVEDIC APPROACH TO RHEUMATOID ARTHRITIS |
Accepted |
| 3864 |
Nikita Rolekar |
STUDY ON IMPACT OF SKIN REHABILITATION MASSAGE THERAPY ON IMMATURE SCAR IN BURN VICTIM |
Accepted |
| 3865 |
Ilakkiya |
MORPHOLOGY OF CORONARY SINUS OSTIUM AND THEBESIAN VALVE |
Accepted |
| 3866 |
Humayra Rumu |
EFFECTIVENESS OF ZINC SUPPLEMENTATION WITH TOPICAL RETINOIDS IN ACNE VULGARIS PATIENTS: A RANDOMIZED, DOUBLE- BLIND, PLACEBO-CONTROLLED TRIAL |
Accepted |
| 3867 |
Sumayra Jhumu |
EVALUATION OF SERUM LIPID PROFILE IN POSTMENOPAUSAL WOMEN |
Accepted |
| 3868 |
Danyalakshmi P.G.S. |
ADVANCES IN GOUT MANAGEMENT: FOCUS ON PREVALENCE, IMAGING, AND TARGETED TREATMENT APPROACHES |
Accepted |
| 3869 |
Ravindra Babu |
A COMPARATIVE STUDY ON CLINICO-ETIOLOGICAL PROFILE AND MANAGEMENT OF HYPONATREMIA IN TERTIARY CARE HOSPITAL |
Accepted |
| 3870 |
Meeval |
CASE REPORT ON RODENTICIDE POISONING |
Accepted |
| 3871 |
Tejaswini Ummiti |
REVIEW ARTICLE ON ORODISPERSIBLE TABLETS |
Under Review |
| 3872 |
Priyansh |
THE ROLE OF AYURVEDA IN WELLNESS TOURISM: ANCIENT WISDOM FOR MODERN WELL-BEING
|
Accepted |
| 3873 |
Melese Alemu |
MAJOR REPRODUCTIVE HEALTH PROBLEMS OF DAIRY CATTLE IN ETHIOPIA: A REVIEW |
Under Review |
| 3874 |
Padmini H.N. |
DESIGN EXPERT SUPPORTED MATHEMATICAL OPTIMIZATION OF METFORMIN HYDROCHLORIDE TABLETS: INVITRO EVALUATION |
Under Review |
| 3875 |
Gnamien Marcel |
Anticandidosis activity of aqueous and ethanolic extracts of Harungana madagascariensis, Zanthoxylum leprieurii and Xylopia aethiopica. |
Under Review |
| 3876 |
A. Myna |
METHOD DEVELOPMENT AND VALIDATION FOR THE QUANTITATIVE ESTIMATION OF TRAMETINIB IN API FORM AND MARKETED TABLET DOSAGE FORM BY RP-HPLC |
Accepted |
| 3877 |
B.Sai Sree Vardhan |
“INDUCED PLURIPOTENT STEM CELL THERAPY IN PARKINSON DISEASE ”:EXPLORING BENEFITS , COST AND RISK |
Accepted |
| 3878 |
S.Lakshmi Sai Lahari |
IMPROVE PATIENT ENGAGEMENT AND HEALTH OUTCOMES THROUGH DATA- DRIVEN METHODOLOGY |
Accepted |
| 3879 |
SURUCHI |
A Review On Cleaning Validation Used In Pharmaceutical Industry |
Under Review |
| 3880 |
Mahmoud M.Alburyhi |
FORMULATION AND DEVELOPMENT OF FAMOTIDINE ORODISPERSIBLE TABLETS |
Accepted |
| 3881 |
Bhavya K.B. |
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF VALACYLOVIR BY: REVIEW |
Accepted |
| 3882 |
beeula |
IMPORTANCE OF SALIVARY PROTEINS AND ENZYMES IN ORAL CAVITY - A REVIEW |
Accepted |
| 3883 |
S. Lakshmi Sai Lahar |
IMPROVE PATIENT ENGAGEMENT AND HEALTH OUTCOMES THROUGH DATA-DRIVEN METHODOLOGY |
Under Review |
| 3884 |
Pavan Kumar |
DELVING INTO THE COLLECTIVE AWARENESS AND ATTITUDE TOWARDS MEDICINE AMONG THE RURAL POPULATION: A COMMUNITY SURVEY |
Accepted |
| 3885 |
Mounika Metta |
BRIDGING THE GAP: COMPUTATIONAL APPROACHES FOR INTEGRATING MEDICAL DATA AND INFORMATICS |
Accepted |
| 3886 |
Sakshi |
Uterine didelphys with Obstructed Hemivagina and Ipsilateral Renal Anomaly: OHVIRA SYNDROME – A Case Report |
Accepted |
| 3887 |
Juveriya Sulthana |
A REVIEW ARTICLE ON INFERTILITY IN MALES AND FEMALE |
Accepted |
| 3888 |
Jaipal |
REVIEW ARTICLE ON KAPHAJA KASA AND ITS AYURVEDIC MANAGEMENT |
Accepted |
| 3889 |
Fareed |
ASSESSMENT OF RIFLE CRITERIA IN TERITIARY CARE HOSPITALS |
Under Review |
| 3890 |
SHANKI |
IMPACT OF JUNK FOOD ON CHILDREN |
Accepted |
| 3891 |
SHANKI |
IMPACT OF JUNK FOOD ON CHILDREN |
Under Review |
| 3892 |
LUCRECE MARCELLINE |
AN ALGORITHMIC APPROACH TO THE MOLECULAR DIAGNOSIS OF ALPHA THALASSEMIA MUTATIONS IN GABONESE PATIENTS WITH SICKLE CELL TRAIT |
Accepted |
| 3893 |
Vishaka Kulkarni |
EVALUATION OF ANTIOBESITY ACTIVITY OF METHANOLIC EXTRACT OF CARALLUMA TUBERCULATA AERIAL PARTS ON HIGH FAT DIET-INDUCED OBESE WISTAR RATS
|
Accepted |
| 3894 |
Mogal Bhushan B. |
IN VIVO - ACUTE ORAL TOXICITY STUDY OF
RAS SINDOOR IN ALBINO RATS.
|
Accepted |
| 3895 |
Sarah |
EFFICIENCY OF DIFFERENT INTERNAL BLEACHING TECHNIQUES ON DISCOLORED TEETH:IN VITRO STUDY |
Accepted |
| 3896 |
Karin |
AN IN-DEPTH INTRODUCTION TO COOKING WITH SALT BLOCKS |
Under Review |
| 3897 |
Pratha |
A LITERARY REVIEW ON VISHAGHNA (ANTI-TOXIC) PROPERTY OF GAIRIKA (RED OCHRE) |
Accepted |
| 3898 |
Gitarani Choubey |
COVID-19 PANDEMIC AND RESEARCH IN ODISHA |
Accepted |
| 3899 |
Nasir Khan |
ASSESSMENT OF PREOPERATIVE ANXIETY IN PATIENTS UNDERGOING MAJOR GENERAL SURGERIES |
Under Review |
| 3900 |
Merugu Mahesh |
A NOVEL RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF NILOTINIB IN BULK AND PHARMACEUTICAL FORMULATIONS |
Accepted |
|
|
SJIF Impact Factor: 8.158
